Journal profile · Obstetrics & Gynecology

Reproductive BioMedicine Online

ISSN 1472-6483 · eISSN 1472-6491 · Elsevier · ENGLAND · Monthly · Founded 2000

Reproductive BioMedicine Online: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 3.77; hybrid open access; APC about USD 3,650; median 142 days to acceptance (125 articles, last 24 months); community-reported acceptance: fairly easy; 377 articles in 2025; indexed in SCIE and Scopus.

Impact factor3.77Latest value listed by LetPub
CAS zoneZone 2 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 2 · Medicine
Review time142 daysMedian, submission to acceptance · 125 articles, last 24 months · PubMed
APCUSD 3,650Hybrid journal: charged only for open-access articles
AcceptanceFairly easyCommunity average
Articles per year3772025 · OpenAlex count

Scope

Aims, scope and focus

Reproductive BioMedicine Online is published by Elsevier and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Reproductive Biology and Fertility, Ovarian function and disorders and Assisted Reproductive Technology and Twin Pregnancy, together about 44.4% of its articles. Its main subfields are Reproductive Medicine. (generated from OpenAlex topic counts and CAS ranking data)

An international journal devoted to biomedical research on human conception and the welfare of the human embryo.Reproductive BioMedicine Online is a journal that covers the formation, growth and differentiation of the human embryo. It is intended to bring to public attention new research on biological and clinical research on human reproduction. The journal's audience includes researchers, clinicians, practitioners, academics and patients.The period of human embryonic growth covered is between the formation of the primordial germ cells in the fetus until mid-pregnancy. Studies progressing to birth and later are published if they have a direct bearing on events in the earlier stages of pregnancy.

From the journal's Aims & Scope

Research area (LetPub): Obstetrics & Gynecology

Editor-in-chief Juan AntonioPublisher website

Editorial board by country: 2 in mainland China (about 2%); most named United Kingdom 25, United States 18, Italy 16, Spain 14, Türkiye 8 (130 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Reproductive Biology and FertilityMedicine20.4%
  2. Ovarian function and disordersMedicine14%
  3. Assisted Reproductive Technology and Twin PregnancyMedicine10%
  4. Reproductive Health and TechnologiesMedicine9.9%
  5. Prenatal Screening and DiagnosticsMedicine9%
  6. Sperm and Testicular FunctionMedicine5.5%
  7. Reproductive System and PregnancyImmunology and Microbiology4.9%
  8. Endometriosis Research and TreatmentMedicine4.1%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
LevelCategoryZone
MajorMedicineZone 2
MinorObstetrics & GynecologyZone 2
MinorReproductive BiologyZone 2

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
LevelCategoryZone
MajorMedicineZone 2
MinorObstetrics & GynecologyZone 2
MinorReproductive BiologyZone 2

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
LevelCategoryZone
MajorMedicineZone 2
MinorObstetrics & GynecologyZone 2
MinorReproductive BiologyZone 2

Top journal: noReview journal: no

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

PubMedPublisher website

Other: Crossref

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
3.77LetPub ·
Impact factor (publisher)
3.9Publisher website ·
CiteScore 2026-06
6.8LetPub ·
CiteScore (publisher)
6.8Publisher website ·
SJR 2026-06
1.21LetPub ·
SNIP 2026-06
1.22LetPub ·
h-index
100LetPub ·
h-index
164OpenAlex ·
i10-index
3,821OpenAlex ·
2-year mean citedness
2.09OpenAlex ·
Self-citation rate
10.3%LetPub ·
Share of gold OA articles
24.55%LetPub ·

Volume

Articles per year
229LetPub ·

Articles by year OpenAlex count · 9,299 in total · the current year is incomplete

YearArticlesOpen accessCitations
202630611155
2025377162748
20244511911,568
20234321682,794
20223771193,872
20213101285,455

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

142 daysMedian, submission to acceptance · P25–P75 101 days – 185 days

Acceptance to online
median 3 days (125 articles)
Submission to online
median 145 days
Sample
125 articles with submission and acceptance dates (611 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
3–8 weeksLetPub ·
Average acceptance (community reports)
Fairly easyLetPub ·
Acceptance rate (publisher)
16%Publisher website ·
First decision after review
55 daysPublisher website ·
Submission to acceptance
114 daysPublisher website ·
Acceptance to publication
7 daysPublisher website ·
Peer review
Single anonymous peer reviewPublisher website

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

SourceAPCFee waiverLicenseObserved
OpenAlexUSD 3,650 / EUR 3,410 / GBP 2,920 / JPY 452,710——
Publisher websiteUSD 3,850——

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare2 items from the author guidelines
Highlights
Optional
Graphical abstract
Optional
Publisher website · model-extracted, each line checked against the text
Article types accepted7, with length limits
  1. full length articlesFull Length Articles: a full-length report of original basic or clinical investigation.Length not stated
  2. original researchFull Length Articles: a full-length report of original basic or clinical investigation. A Structured Abstract (which must include the following headings: Resear…Length not stated
  3. reviewFull Length Articles: a full-length report of original basic or clinical investigation. A Structured Abstract (which must include the following headings: Resear…Length not stated
  4. review articleFull Length Articles: a full-length report of original basic or clinical investigation. A Structured Abstract (which must include the following headings: Resear…Length not stated
  5. review articlesReview articles: a comprehensive review of prior publications relating to an important clinical subject.Length not stated
  6. short communicationFull Length Articles: a full-length report of original basic or clinical investigation. A Structured Abstract (which must include the following headings: Resear…main text ≤ 1,000 words
  7. short communicationsShort communications: these must not exceed 1,000 words with no more than one table or illustration and 5 references.Length not stated
Publisher website
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Plagiarism, Preprints
AI use Declaration of generative AI in scientific writing

Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…

Source ↗Publisher website ·
Authorship Authorship

All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.

Source ↗Publisher website ·
Conflicts of interest Declaration of interest

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places:…

Source ↗Publisher website ·
Data availability Data Availability statement

The inclusion of a Data Availability Statement is a requirement for articles published in RBMO. Data Availability Statement provides the information of the availability of data underlying the research results described in the article and reports the means/identifier to access the data. This may also be a requirement of your funding body or institution. You will have the opportunity to provide a da…

Source ↗Publisher website ·
Publication ethics Ethical approval documentation

Ethical approval documentation Model summary

Ethical approval documentation is mandatory when submitting full-length articles and short communications, but not mandatory for other article types (reviews, commentaries). The documentation may take various forms. Authors would normally submit all proposed studies for consideration by their institution's Internal Review Board (IRB) or Ethics Committee. A copy of the response letter from the IRB …

Source ↗Publisher website ·
License & copyright Copyright

Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.Subscribers may reproduce tables of contents or prepare lists of articles includ…

Source ↗Publisher website ·
Open access Open access

Please visit our Open Access page for more information about open access publishing in this journal.

Source ↗Publisher website ·
Peer review Peer review

Peer review process Model summary

This journal operates a single anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…

Source ↗Publisher website ·
Plagiarism

Plagiarism check Model summary

To verify compliance, your article may be checked by Crossref Similarity Check and other originality or duplicate checking software.

Source ↗Publisher website ·
Preprints Preprint references

Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the nam…

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Elsevier
Country or region
ENGLAND
Language
English
Frequency
Monthly
Founded
2000
ISSN
1472-6483
Electronic ISSN
1472-6491
Official links

FAQ

Frequently asked questions about Reproductive BioMedicine Online

What CAS zone is Reproductive BioMedicine Online in?

In the 2025 upgraded edition of the CAS Journal Ranking, Reproductive BioMedicine Online is in Zone 2 of Medicine, and in Zone 2 of the minor category Obstetrics & Gynecology / Reproductive Biology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Reproductive BioMedicine Online?

The latest impact factor listed by LetPub is 3.77; CiteScore 6.8, h-index 164.

How long does peer review take at Reproductive BioMedicine Online?

Based on the dates recorded on 125 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 142 days (interquartile range 101–185 days); authors report an average review time of 3–8 weeks; the community-reported acceptance is “Fairly easy”; the journal's website gives an acceptance rate of 16%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of Reproductive BioMedicine Online?

According to the journal's author guidelines: Highlights: Optional; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Where are the editorial board members of Reproductive BioMedicine Online based?

Of the 130 board members whose country the journal's board page names, 2 (about 2%) are in mainland China; the countries named most often are United Kingdom (25), United States (18) and Italy (16). Counted from the institutions listed on the board page; for reference only.

Which databases index Reproductive BioMedicine Online?

According to LetPub and DOAJ records, Reproductive BioMedicine Online is indexed in SCIE and Scopus. The journal's website also lists PubMed; that list has not been checked against each database.

Is Reproductive BioMedicine Online open access, and what is the APC?

Reproductive BioMedicine Online is a hybrid journal. For open-access publication: APC about USD 3,650.

Sources and updates

The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .